Related Experiment Video
Updated: Jul 16, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Immunomodulatory effects of fosfomycin in experimental human endotoxemia
Robert Sauermann1, Claudia Marsik, Ilka Steiner
1Department of Clinical Pharmacology, Division of Pharmacokinetics, Medical University of Vienna, Vienna, Austria.
Abstract:
To evaluate the effect of fosfomycin on proinflammatory cytokines, a bolus of 2 ng of bacterial lipopolysaccharide/kg of body weight was injected intravenously into healthy volunteers. After 2 h, subjects received 8 g of fosfomycin or placebo in a randomized crossover study design. The resulting concentrations of tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-6 expressed as protein and mRNA levels were almost identical with and without fosfomycin.
